Our data indicate that, despite the tumors obtained from mice injected with CD64-CR T cells, with or without the anti-B7-H3 mAb, emitted significantly higher fluorescence than that of tumor controls, only the combination of CD64-CR T cells with the 376.96 mAb significantly inhibited tumor mass growth. This evidence concerns the gene FCGR1A and neoplasm.